{"transactions":[{"id":4639293,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:06:42.000Z","date":"2026-10-09","kind":"grant","planned":false,"acquired":true,"shares":2977,"price":1.08,"value":3215.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":116174,"source":{"system":"sec-edgar","filing":"0001437749-26-032562","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813667/000143774926032562/rdgdoc.xml","form_type":"4"}},{"id":4627659,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:25.000Z","date":"2026-09-25","kind":"grant","planned":false,"acquired":true,"shares":6697,"price":1.41,"value":9442.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":113197,"source":{"system":"sec-edgar","filing":"0001437749-26-031362","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813667/000143774926031362/rdgdoc.xml","form_type":"4"}},{"id":4617710,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-15T16:42:25.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":5504,"price":1.47,"value":8090.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":105580,"source":{"system":"sec-edgar","filing":"0001437749-26-030414","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813667/000143774926030414/rdgdoc.xml","form_type":"4"}},{"id":671693,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-01T20:09:17.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":6822,"price":1.6,"value":10915.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":100076,"source":{"system":"sec-edgar","filing":"0001437749-26-029408","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926029408/rdgdoc.xml","form_type":"4"}},{"id":686304,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-17T20:22:42.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":6615,"price":1.65,"value":10914.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":93254,"source":{"system":"sec-edgar","filing":"0001437749-26-028187","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926028187/rdgdoc.xml","form_type":"4"}},{"id":698352,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-04T20:10:17.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":5010,"price":1.59,"value":7965.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":86639,"source":{"system":"sec-edgar","filing":"0001437749-26-025655","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926025655/rdgdoc.xml","form_type":"4"}},{"id":705436,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-21T20:14:20.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":4907,"price":1.83,"value":8979.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":81629,"source":{"system":"sec-edgar","filing":"0001437749-26-023946","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926023946/rdgdoc.xml","form_type":"4"}},{"id":714140,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-07T20:56:05.000Z","date":"2026-07-02","kind":"grant","planned":false,"acquired":true,"shares":2534,"price":1.91,"value":4839.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":76722,"source":{"system":"sec-edgar","filing":"0001437749-26-022941","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926022941/rdgdoc.xml","form_type":"4"}},{"id":724996,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-29T20:21:11.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":67150,"price":1.72,"value":115498.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for 50% of 2025 annual cash bonus"}],"balance_after":74188,"source":{"system":"sec-edgar","filing":"0001437749-26-022001","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926022001/rdgdoc.xml","form_type":"4"}},{"id":729847,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-23T20:17:54.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":1803,"price":1.82,"value":3281.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":7038,"source":{"system":"sec-edgar","filing":"0001437749-26-021444","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926021444/rdgdoc.xml","form_type":"4"}},{"id":745577,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-09T20:14:15.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1593,"price":2.06,"value":3281.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":5235,"source":{"system":"sec-edgar","filing":"0001437749-26-019994","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926019994/rdgdoc.xml","form_type":"4"}},{"id":762951,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-27T20:11:26.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":1491,"price":2.2,"value":3280.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock granted in lieu of cash for portion of base salary"}],"balance_after":3642,"source":{"system":"sec-edgar","filing":"0001437749-26-018545","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926018545/rdgdoc.xml","form_type":"4"}},{"id":770346,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-20T22:03:39.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0.7,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.7,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-26-064653","document":"tm267728-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465926064653/tm267728-3_4seq1.xml","form_type":"4"}},{"id":949272,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:05:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":56187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of the grant"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant."}],"balance_after":56187,"derivative":{"exercise_price":3.95,"exercise_date":"2026-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":56187},"source":{"system":"sec-edgar","filing":"0001437749-26-000604","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774926000604/rdgdoc.xml","form_type":"4"}},{"id":1045461,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock","published_at":"2025-09-09T20:14:01.000Z","date":"2025-09-06","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock share represents a contingent right to receive one share of Imunon, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 6, 2024, Ms. Lindborg received restricted stock representing 1,667 shares (as adjusted for the reverse stock split) subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock shares vest, the vested shares are automatically converted to vested common stock on a one-for-one basis on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 6, 2024, Ms. Lindborg received restricted stock representing 1,667 shares (as adjusted for the reverse stock split) subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock shares vest, the vested shares are automatically converted to vested common stock on a one-for-one basis on the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-25-028685","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774925028685/rdgdoc.xml","form_type":"4"}},{"id":1045460,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-09T20:14:01.000Z","date":"2025-09-06","kind":"exercise","planned":false,"acquired":true,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquisition of common stock resulting from vesting of 100% of the restricted stock granted to Ms. Lindborg on September 6, 2024."}],"balance_after":3584,"source":{"system":"sec-edgar","filing":"0001437749-25-028685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774925028685/rdgdoc.xml","form_type":"4"}},{"id":1073681,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-06T20:21:18.000Z","date":"2025-08-04","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of the grant"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":9.2,"exercise_date":"2025-08-04","expiration_date":"2035-08-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-25-025084","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774925025084/rdgdoc.xml","form_type":"4"}},{"id":1202597,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T20:15:28.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of the grant"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":0.8651,"exercise_date":"2025-03-14","expiration_date":"2035-03-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-25-008256","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774925008256/rdgdoc.xml","form_type":"4"}},{"id":1315836,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T22:32:08.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock units (\"RSUs\") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024."}],"balance_after":48229,"source":{"system":"sec-edgar","filing":"0001104659-25-000889","document":"tm251864-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925000889/tm251864-4_4seq1.xml","form_type":"4"}},{"id":1379157,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-10-31T23:57:11.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment reports a new transaction that was inadvertently omitted from the Form 4 filed on September 10, 2024 by the Reporting Person.  Each restricted stock unit represents a contingent right to receive one share of Imunon, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 6, 2024, Ms. Lindborg received restricted stock units representing 25,000 shares subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 6, 2024, Ms. Lindborg received restricted stock units representing 25,000 shares subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-24-032858","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774924032858/rdgdoc.xml","form_type":"4/A","original_submission_date":"2024-09-10"}},{"id":1411512,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-10T20:49:03.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":63602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of the grant"},{"field":"shares","element":"transactionShares","label":"F3","text":"Option granted in lieu of cash payment increases."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows 1/2 on the date of grant; 1/4 on the one year anniversary of the grant; and 1/4 on the second anniversary of the date of grant."}],"balance_after":302768,"derivative":{"exercise_price":1.04,"exercise_date":"2024-09-06","expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":63602},"source":{"system":"sec-edgar","filing":"0001437749-24-028877","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774924028877/rdgdoc.xml","form_type":"4"}},{"id":1432037,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Imunon Common Stock","published_at":"2024-08-16T12:03:50.000Z","date":"2024-08-15","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.98,"value":24500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The CEO and president purchased the shares on the open market."}],"balance_after":264166,"source":{"system":"sec-edgar","filing":"0001437749-24-027060","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774924027060/rdgdoc.xml","form_type":"4"}},{"id":1480022,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T10:13:49.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of the grant"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary"}],"balance_after":239166,"derivative":{"exercise_price":1.22,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001437749-24-020264","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774924020264/rdgdoc.xml","form_type":"4"}},{"id":1518464,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T20:24:45.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of the grant"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary"}],"balance_after":126666,"derivative":{"exercise_price":1.48,"exercise_date":"2025-05-13","expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001437749-24-016643","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774924016643/rdgdoc.xml","form_type":"4"}},{"id":1573857,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-18T21:04:28.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second anniversary of the date of grant."}],"balance_after":14166,"derivative":{"exercise_price":0.86,"exercise_date":"2024-03-15","expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001437749-24-008334","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774924008334/rdgdoc.xml","form_type":"4"}},{"id":1579174,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-14T00:57:42.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":241935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant of restricted stock awards (\"RSAs\") to the Reporting Person as reported herein was approved by the board of directors of the Issuer on March 11, 2024 (\"Grant Date\") as part of the Issuer's grant of equity awards in the ordinary course. The RSAs shall vest in equal yearly installments over the course of two (2) years, with vesting occurring on each of the first and second anniversary of the Grant Date."}],"balance_after":423435,"source":{"system":"sec-edgar","filing":"0001104659-24-034095","document":"tm248822-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924034095/tm248822-4_4seq1.xml","form_type":"4"}},{"id":1789667,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-05T21:16:20.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":11500,"price":1.7741,"value":20402.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.74 to $1.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":181500,"source":{"system":"sec-edgar","filing":"0001104659-23-098326","document":"tm2325491-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923098326/tm2325491-1_4seq1.xml","form_type":"4"}},{"id":1814031,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-07T10:02:05.000Z","date":"2023-08-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of August 2, 2023, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":170000,"source":{"system":"sec-edgar","filing":"0001104659-23-088000","document":"tm2322868-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923088000/tm2322868-1_4seq1.xml","form_type":"4"}},{"id":1915039,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-24T10:42:36.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares were fully vested upon grant."}],"balance_after":135000,"source":{"system":"sec-edgar","filing":"0001104659-23-048632","document":"tm2313513-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923048632/tm2313513-1_4seq1.xml","form_type":"4"}},{"id":1943935,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-21T20:39:46.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Imunon, Inc. Common Stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant."}],"balance_after":9666,"derivative":{"exercise_price":1.32,"exercise_date":"2023-03-17","expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-23-007405","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774923007405/rdgdoc.xml","form_type":"4"}},{"id":2068934,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-04T12:36:29.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of December 7, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001104659-23-000636","document":"tm231419-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923000636/tm231419-1_4seq1.xml","form_type":"4"}},{"id":2232069,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true}}],"security":"Option to Purchase Celsion Common Stock","published_at":"2022-06-15T20:47:07.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant."}],"balance_after":7666,"derivative":{"exercise_price":1.93,"exercise_date":"2022-06-13","expiration_date":"2032-06-13","underlying":"Celsion Corporation Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-22-015068","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774922015068/rdgdoc.xml","form_type":"4"}},{"id":2349072,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true}}],"security":"Option to Purchase Celsion Corporation Common Stock","published_at":"2022-03-07T23:01:03.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the per share per share fair value of the common stock based on the closing price of a share of Celsion Stock on the date of the award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/3 on the date of grant; 1/3 on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant."}],"balance_after":5166,"derivative":{"exercise_price":4.6,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Celsion Corporation Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-22-005432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774922005432/rdgdoc.xml","form_type":"4"}},{"id":2678538,"issuer":{"id":8041,"kind":"organization","name":"Imunon, Inc.","symbol":"IMNN"},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":true}}],"security":"Option to Purchase Celsion Corporation Common Stock","published_at":"2021-06-08T20:21:16.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the closing price of Celsion Corporation Common Stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1/3 on January 1, 2022; 1/3 on January 1, 2023; and 1/3 on January 1, 2024."}],"balance_after":40000,"derivative":{"exercise_price":1.24,"exercise_date":"2022-06-04","expiration_date":"2031-06-04","underlying":"Celsion Corporation Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-21-014321","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/749647/000143774921014321/rdgdoc.xml","form_type":"4"}},{"id":2973440,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head Global Clin Research"}}],"security":"Call Option (right to buy)","published_at":"2020-11-19T23:00:51.000Z","date":"2020-11-17","kind":"purchase","acquired":true,"shares":200,"price":11000,"value":2200000.0,"ownership":{"direct":true},"balance_after":200,"derivative":{"exercise_price":10,"exercise_date":"2020-11-17","expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-127446","document":"tm2036490-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920127446/tm2036490-1_4.xml","form_type":"4"}},{"id":3129305,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head Global Clin Research"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-01T21:32:04.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, awarded on June 1, 2020 under the Issuer's 2014 Stock Incentive Plan, shall vest and become exercisable as to 50,000 of the underlying shares on February 28, 2021 (\"First Vesting Date\"), and the remaining 50,000 shares underlying the Option shall vest and become exercisable in equal quarterly installments thereafter until fully vested and exercisable on the second anniversary of the First Vesting Date, provided Reporting Person remains employed by Issuer from the date of grant through each applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":7.67,"exercise_date":"2021-02-28","expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-068501","document":"tm2021119-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920068501/tm2021119-2_4.xml","form_type":"4"}},{"id":3129304,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":18220,"kind":"person","name":"Lindborg Stacy","position":1,"cik":"0001813667","reported_name":"Lindborg Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head Global Clin Research"}}],"security":"Common Stock","published_at":"2020-06-01T21:32:04.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on June 1, 2020 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 100% of the award on December 31, 2020, provided that the Reporting Person remains continuously employed by Issuer from the date of grant through the vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-20-068501","document":"tm2021119-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920068501/tm2021119-2_4.xml","form_type":"4"}}]}